* Aspira Women's Health Inc AWH.OQ AWH.O is expected
to show a
rise in quarterly revenue when it reports results on May 11.
* The Austin Texas-based company is expected to report a
35.1% increase in revenue to $2.557 million from $1.89 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Aspira Women's
Health Inc
is for a loss of 5 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Aspira
Women's
Health Inc is $2, above its last closing price of $0.30.
This summary was machine generated May 10 at 02:01 GMT. All
figures in US dollars unless otherwise stated